Influence of Short AV Delay Permanent Pacing on Matrix Metalloproteinase Levels
Influence of Short AV Delay Pacing on Matrix Metalloproteinase Lives
1 other identifier
interventional
20
1 country
1
Brief Summary
As potential biomarkers of pressure-related aortic damage, matrix metalloproteinases (MMP) have been implicated in the pathogenesis of aortic aneurysm because of the important role they play in connective tissue homeostasis. In particular, a significant reduction in initially elevated serum MMP - 9 concentrations, compared with healthy controls, demonstrated after the aortic repair in patients with abdominal aortic aneurysm implies MMPs pivotal role in aortic aneurysms. Besides, due to an active degradation and repair processes taking place in the vascular wall governed by the balance between MMP enzymes and their inhibitors, MMP - 9, expression of which is predominantly associated with disruption of aortic elastic fibers, can also be detected in the serum of healthy subjects. Indeed, mechanical stress-induced upregulation of genes and their products stimulate MMP expression in the vascular wall, which is responsible for extracellular matrix degradation. Herein, it was hypothesized that reducing the acceleration rate of aortic pressure (aortic peak dP/dt) may decrease the mechanical stretch on the aortic wall which, may in turn, reduce the expression and serum levels of MMP-9.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2018
CompletedFirst Submitted
Initial submission to the registry
October 28, 2018
CompletedFirst Posted
Study publicly available on registry
November 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2018
CompletedDecember 11, 2018
December 1, 2018
1 month
October 28, 2018
December 8, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Change in MMP - 9 serum concentration from baseline to at the end of 3 weeks follow-up
MMP-9 serum concentration will be measured before and after short AV delay (wide QRS) pacing. Change in MMP-9 levels will be measured.
3 weeks
Study Arms (1)
Short AV-delay pacing
EXPERIMENTALParticipants will be their own control. Serum samples will be collected at baseline while the participants were in sinus rhythm and after 3 weeks of short AV-delay pacing serum samples will be recollected to measure matrix metalloproteinase levels .
Interventions
Atrioventricular delays are going to be adjusted as 60 milisecond shorter than the patients' native PR intervals in patients with already implanted permanent pacemakers.
Eligibility Criteria
You may qualify if:
- Normal LV systolic function (EF\>50%),
- Healthy conduction systems
- Noncritical coronary stenoses or normal coronary arteries
- Ventricular pacing rate \<10% in the last 6 months detected at the interrogation of the pacemakers
You may not qualify if:
- Intra-ventricular conduction abnormalities (baseline QRS \>100 msec.),
- Mild to moderate aortic or mitral valve disease
- Presence of atrial fibrillation
- LV systolic dysfunction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology
Istanbul, 34290, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
October 28, 2018
First Posted
November 1, 2018
Study Start
October 15, 2018
Primary Completion
November 15, 2018
Study Completion
November 15, 2018
Last Updated
December 11, 2018
Record last verified: 2018-12